Promising phase I results against new HIV target

被引：3

|

作者：

Whelan, J

机构：

来源：

DRUG DISCOVERY TODAY | 2004年 / 9卷 / 19期

关键词：

D O I：

10.1016/S1359-6446(04)03247-7

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：823 / 823

页数：1

相关论文

共 50 条

[41] NEW DRUG IN PHASE I: RECENT RESULTS AND THE STATUS IN JAPAN
Tamura, Tomohide
JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S437 - S437
[42] Promising results with siRNA against PCSK9
Irene Fernández-Ruiz
Nature Reviews Cardiology, 2017, 14 (5) : 252 - 252
[43] Encouraging results for targeted therapy against childhood medulloblastoma in a Phase I study
不详
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (08) : 1250 - 1250
[44] Encouraging results for targeted therapy against childhood medulloblastoma in Phase I study
不详
EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (08) : 1168 - 1168
[45] Innate immunity against HIV: a priority target for HIV prevention research
Borrow, Persephone
Shattock, Robin J.
Vyakarnam, Annapurna
RETROVIROLOGY, 2010, 7
[46] Innate immunity against HIV: a priority target for HIV prevention research
Persephone Borrow
Robin J Shattock
Annapurna Vyakarnam
Retrovirology, 7
[47] Phase I/II clinical trial of gene therapy for severe hemophilia B delivers promising results
不详
EXPERT REVIEW OF HEMATOLOGY, 2011, 4 (01) : 7 - 7
[48] Promising phase I trial results for TG4040 vaccine in patients with chronic hepatitis C
Katrina Ray
Nature Reviews Gastroenterology & Hepatology, 2011, 8 (8) : 420 - 420
[49] New promising vaccine candidate against norovirus
Riedmann, Eva M.
HUMAN VACCINES, 2011, 7 (06): : 595 - 595
[50] Vaccine against CMV promising in Phase II trial
Riedmann, Eva M.
HUMAN VACCINES, 2011, 7 (05): : 492 - 492

← 1 2 3 4 5 →